Tyra Biosciences Inc (TYRA)

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

TYRA BIOSCIENCES AND BCAN ESTABLISH MAY 21 AS UPPER TRACT UROTHELIAL CANCER (UTUC) AWARENESS DAY

TYRA BIOSCIENCES AND BCAN ESTABLISH MAY 21 AS UPPER TRACT UROTHELIAL CANCER (UTUC) AWARENESS DAY PR...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights

Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights PR Newswire CARLSBAD...

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Tyra Biosciences to Participate in Upcoming Investor Conferences

Tyra Biosciences to Participate in Upcoming Investor Conferences PR Newswire CARLSBAD, Calif., May 7, 2026...

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report